Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

Abroad (travel likely)RecruitingPHASE2

Conditions

Alzheimer Disease · Mild Cognitive Impairment · Dementia · Healthy Volunteers

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nuclear Imaging Institute, Englewood, New Jersey, United States
Contact: Study coordinator (Barbara Blanchfield) · 973-255-4955

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neurologic Stem Cell Treatment Study

Neurologic Disorders · Nervous System Diseases · Neurodegenerative Diseases

Abroad (travel likely)Recruiting

Westport, United States · Coral Springs, United States

Study to Understand Novel Biomarkers in Researching Dementia

Alzheimer Disease · Mild Cognitive Impairment · Dementia

Abroad (travel likely)Recruiting

St Louis, United States

Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers

Mild Cognitive Impairment · Alzheimer Disease · Dementia

Abroad (travel likely)Recruiting

Greenfield Park, Canada

Fisetin in Mild Alzheimer's Disease

Alzheimer s Disease · Alzheimer Dementia · Alzheimer Dementia (AD)

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada